- For Patients
- Introduction to the Marshall Protocol
- Length of the MP
- Immunopathology
- Managing immunopathology
- Food and drink
- Light restriction
- Vitamin D metabolite calculator - get feedback on vitamin D results
- Therapeutic probe - best method for determining MP suitability
- Starting the Marshall Protocol
- Resources for patients
- Marshall Protocol summary
- Palliative vs. curative treatments
- Patient interviews on Bacteriality
- Non-MP treatments
- Glossary
- The Protocol
- Marshall Protocol summary
- Publications and presentations
- Science behind immunopathology
- Science behind olmesartan (Benicar)
- Safety of olmesartan
- Resources for physicians
- Vitamin D metabolite calculator - get feedback on vitamin D results
- Therapeutic probe - best method for determining MP suitability
- Physicians' concerns about the MP
- Notice for emergency medical personnel
- The Pathogenesis
- Publications and presentations
- Science behind Marshall Pathogenesis
- Microbes in the human body
- Successive infection and variability in disease
- Autoimmune theory of disease
- Science behind vitamin D
- Metabolism of vitamin D and the VDR
- Th1 Spectrum Disorder - how chronic inflammatory diseases are related
- Transmission of bacteria and onset of chronic disease
- Evolutionary perspective on disease
- Incidence and prevalence of disease
- Evidence that chronic disease is caused by pathogens
- Diseases
- Foundation
- Related Sites
Steroid inhalers
Steroid inhalers suppress the innate immune responseThe body's first line of defense against intracellular and other pathogens. According to the Marshall Pathogenesis the innate immune system becomes disabled as patients develop chronic disease., reduce immunopathologyA temporary increase in disease symptoms experienced by Marshall Protocol patients that results from the release of cytokines and endotoxins as disease-causing bacteria are killed., and delay progress for Marshall ProtocolA curative medical treatment for chronic inflammatory disease. Based on the Marshall Pathogenesis. (MP) patients. For patients with obstructive lung diseases such asthma, chronic obstructive pulmonary disease, and sarcoidosis, a bronchiodilator inhaler is superior choice.
MP patients taking steroid inhalers should work with their physicians to switch drugs.
Types of steroid inhalers
- beclomethasone dipropionate (Becotide, Vanceril, Qvar)
- budesonide (Pulmicort)
- flunisolide (Aerobid)
- fluticasone/salmeterol (Advair, Seretide, Viani) - note: salmetrol is a bronchiodilator
- budesonide/formoterol (Symbicort) - note: formetrol is a bronchiodilator
- triamcinolone acetonide (Azmacort)
Patients experiences
I can tell you from personal experience that I too had to get off my steroid inhaler when I started the MP. I was so scared to do this, as my asthma was so bad. Much to my relief, the Benicar was better than the steroid inhaler! I also used a long acting (12-hour) non-steroidal inhaler, but after one year on the MP, I no longer needed it. I do still use the short-acting inhaler four times a day, but only need one puff.
My asthma is triggered by MCS. The MCS has also improved on the MP. I actually once left the house without my inhaler, and the Benicar stopped my asthma attack with in 10 minutes. I should have chewed and put it under my tongue, but I was not thinking. This allows for quicker absorption. I was so impressed that the Benicar could do this.
Lori, MarshallProtocol.com